UBS Group Cuts Nutrien (NYSE:NTR) Price Target to $52.00

Nutrien (NYSE:NTR - Get Free Report) had its price target dropped by stock analysts at UBS Group from $54.00 to $52.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a "neutral" rating on the stock. UBS Group's target price would suggest a potential downside of 0.95% from the company's previous close.

NTR has been the topic of several other reports. Wells Fargo & Company increased their target price on shares of Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a research note on Friday, February 21st. Berenberg Bank increased their price objective on shares of Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a research report on Tuesday. CIBC boosted their target price on Nutrien from $64.00 to $66.00 and gave the company an "outperformer" rating in a research report on Tuesday, February 25th. Mizuho increased their price target on Nutrien from $52.00 to $55.00 and gave the stock a "neutral" rating in a report on Thursday, February 20th. Finally, Royal Bank of Canada restated an "outperform" rating and set a $60.00 price objective on shares of Nutrien in a report on Monday, February 24th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $59.40.

Nutrien Trading Down 1.4 %

NYSE NTR traded down $0.77 during mid-day trading on Wednesday, reaching $52.50. 2,808,612 shares of the stock were exchanged, compared to its average volume of 2,084,802. The stock has a market cap of $25.66 billion, a P/E ratio of 38.32, a P/E/G ratio of 1.19 and a beta of 0.77. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien has a one year low of $43.70 and a one year high of $60.87. The stock has a 50 day simple moving average of $50.86 and a 200-day simple moving average of $49.26.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The business had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. On average, analysts anticipate that Nutrien will post 3.72 EPS for the current year.

Institutional Trading of Nutrien

Hedge funds have recently bought and sold shares of the business. Fairway Wealth LLC purchased a new stake in Nutrien during the fourth quarter worth about $27,000. HHM Wealth Advisors LLC boosted its stake in Nutrien by 331.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock worth $28,000 after purchasing an additional 480 shares during the period. Assetmark Inc. grew its stake in Nutrien by 1,437.5% during the fourth quarter. Assetmark Inc. now owns 738 shares of the company's stock valued at $33,000 after acquiring an additional 690 shares in the last quarter. Asset Planning Inc purchased a new stake in Nutrien in the 4th quarter worth approximately $35,000. Finally, Exchange Traded Concepts LLC boosted its holdings in Nutrien by 96.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company's stock valued at $38,000 after purchasing an additional 416 shares during the period. 63.10% of the stock is currently owned by institutional investors.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.